ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.
Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.
Panacea Biotec Limited issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026, via video conferencing. Shareholders can participate through remote e-voting.
Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).
Nosheen Sheikh, an employee's immediate relative, sold 3,000 equity shares of Panacea Biotec Ltd for ₹12.29 Lakh in a market sale.
Panacea Biotec Ltd reported revenue from operations of ₹199.6 Cr (+19.7% YoY) and net profit of ₹2.2 Cr (-45.0% YoY) for Q1 FY27.
Panacea Biotec will hold a board meeting on August 13, 2026, to approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.
Panacea Biotec Ltd secured a Letter of Award from UNICEF worth approximately Rs.78.24 Crore ($8.205 million). The contract involves supplying bivalent Oral Polio Vaccine during 2028.
Panacea Biotec's subsidiary received a GST Show Cause Notice. The notice alleges a total tax liability of ₹4.06 Crore for FY 2022-23.
Panacea Biotec filed its quarterly shareholding pattern. The filing notes an off-market gift of 2,00,000 shares from Dr. Rajesh Jain to Rajesh Jain (HUF).
Panacea Biotec filed a High Court appeal against an industrial tribunal award involving 23 workmen. The court granted interim relief, preventing coercive steps against the company.
Rajesh Jain HUF acquired 200,000 shares of Panacea Biotec from Dr. Rajesh Jain by gift, increasing promoter holdings to 0.09%. No cash transaction was involved.